ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 740613 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 740613; 2) Community: the network communities that were significantly associated with the response to NSC 740613; 3) Molecule: the relationships between components within communities and NSC 740613; 4) MDR: the compounds that were significantly associated with the NSC 740613.

NSC Compound Enrichment Correlation
NSC 621486 2-Propen-1-one, 1-(1,4-dioxo-2,6,7-trimethylquinoxalin- 3-yl)-3-(2-nitrophenyl)- 0.0119653763676521 0.36763159
NSC 627371 2,1,3-Benzoselanadiazole, nitro-6-(trifluoromethyl)- 0.0119653763676521 -0.22916602
NSC 628676 Furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 9-[(4-aminophenyl)amino]-5,8,8a,9-tetrahydro-5-(4- hydroxy-3,5-dimethoxyphenyl)-, dihydrochloride 0.0119653763676521 0.21242658
NSC 671891 Null 0.0119653763676521 -0.064265916
NSC 681271 1,3,6-Triphenyl-oxazolo(5,4-d)pyrimidin-2',4(1H,3H)-dion 0.0119653763676521 0.45850499
NSC 8120 Claviform 0.0119653763676522 -0.080944456
NSC 742417 C8, carbonyl prodigiosine 0.0131142867047947 -0.13737112
NSC 218476 .beta.-D-Glucopyranose, 6-thio-, 6-(dimethylarsinite) 0.0131142867047949 -0.22738296
NSC 349174 Oxanthrazole 0.0131142867047949 0.23491195
NSC 355644 Anthrapyrazole derivative 0.0131142867047949 0.31508231
Total:102  Current:33    [First] [Prev] [Next] [Last]